3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
7
Carcinoma, Non-Small-Cell Lung
6
Lung Neoplasms
5
Urinary Bladder Neoplasms
4
Mesothelioma, Malignant
4
Urethral Neoplasms
3
Small Cell Lung Carcinoma
3
Oropharyngeal Neoplasms
3
Neuroblastoma
3
Medulloblastoma
3
Ganglioneuroblastoma
3
Cholangiocarcinoma
3
Vulvar Neoplasms
2
Vaginal Neoplasms
2
Ureteral Neoplasms
2
Tongue Neoplasms
2
Prostatic Neoplasms
2
Lymphoid Interstitial Pneumonia
2
Laryngeal Neoplasms
2
Gallbladder Neoplasms
2
Carcinoma, Transitional Cell
2
Brenner Tumor
2
Vomiting
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Solitary Fibrous Tumor, Pleural
1
Sertoli-Leydig Cell Tumor
1
Interventions
Paclitaxel
6
Radiotherapy
2
Pemetrexed
2
Carboplatin
2
Brachytherapy
2
tucatinib
1
seribantumab
1
osimertinib
1
gedatolisib
1
fosaprepitant
1
fluciclovine F-18
1
cobimetinib
1
atezolizumab
1
alovudine
1
Trastuzumab
1
Therapeutics
1
TP protocol
1
Saline Solution
1
Radiation
1
Protons
1
Palliative Care
1
Nivolumab
1
Letrozole
1
Immunoglobulin G
1
Imatinib Mesylate
1
Ifosfamide
1
Gemcitabine
1
Fulvestrant
1
FANG vaccine
1
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Uterine Neoplasms
×
1,2-diaminocyclohexaneplatinum II citrate
×
Clear all
No trials found.